By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Aria Diagnostics said today that it has begun a blinded, multicenter clinical trial that will compare its non-invasive prenatal trisomy 21 screening test with standard screening methods.

The company's test, which is still in development, is based on a sequencing-based method that analyzes cell-free DNA in maternal blood to detect fetal chromosomal abnormalities.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.